Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Effect of Tumor Characteristics and Location on the Extent of Lymph Node Metastases of Head and Neck Cutaneous Squamous Cell Carcinoma.
van Leer B, Leus AJG, van Dijk BAC, van Kester MS, Halmos GB, Diercks GFH, van der Vegt B, Vister J, Rácz E, Plaat BEC. van Leer B, et al. Among authors: van dijk bac, van kester ms, van der vegt b. Front Oncol. 2022 May 30;12:874295. doi: 10.3389/fonc.2022.874295. eCollection 2022. Front Oncol. 2022. PMID: 35707356 Free PMC article.
Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer.
de Heer EC, Zois CE, Bridges E, van der Vegt B, Sheldon H, Veldman WA, Zwager MC, van der Sluis T, Haider S, Morita T, Baba O, Schröder CP, de Jong S, Harris AL, Jalving M. de Heer EC, et al. Among authors: van der sluis t, van der vegt b. J Exp Clin Cancer Res. 2023 Jun 6;42(1):143. doi: 10.1186/s13046-023-02715-z. J Exp Clin Cancer Res. 2023. PMID: 37280675 Free PMC article.
Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer.
de Heer EC, Zois CE, Bridges E, van der Vegt B, Sheldon H, Veldman WA, Zwager MC, van der Sluis T, Haider S, Morita T, Baba O, Schröder CP, de Jong S, Harris AL, Jalving M. de Heer EC, et al. Among authors: van der sluis t, van der vegt b. J Exp Clin Cancer Res. 2023 Aug 28;42(1):220. doi: 10.1186/s13046-023-02800-3. J Exp Clin Cancer Res. 2023. PMID: 37635223 Free PMC article. No abstract available.
Head and neck squamous cell carcinomas do not express EGFRvIII.
Melchers LJ, Clausen MJ, Mastik MF, Slagter-Menkema L, Langendijk JA, van der Laan BF, van der Wal JE, van der Vegt B, Roodenburg JL, Schuuring E. Melchers LJ, et al. Among authors: van der wal je, van der laan bf, van der vegt b. Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):454-62. doi: 10.1016/j.ijrobp.2014.06.035. Int J Radiat Oncol Biol Phys. 2014. PMID: 25304797
Detection of HPV-associated oropharyngeal tumours in a 16-year cohort: more than meets the eye.
Melchers LJ, Mastik MF, Samaniego Cameron B, van Dijk BA, de Bock GH, van der Laan BF, van der Vegt B, Speel EJ, Roodenburg JL, Witjes MJ, Schuuring E. Melchers LJ, et al. Among authors: van dijk ba, van der laan bf, van der vegt b. Br J Cancer. 2015 Apr 14;112(8):1349-57. doi: 10.1038/bjc.2015.99. Epub 2015 Mar 17. Br J Cancer. 2015. PMID: 25867270 Free PMC article.
Viable tumor in salvage neck dissections in head and neck cancer: Relation with initial treatment, change of lymph node size and human papillomavirus.
van den Bovenkamp K, Dorgelo B, Noordhuis MG, van der Laan BFAM, van der Vegt B, Bijl HP, Roodenburg JL, van Dijk BAC, Oosting SF, Schuuring EMD, Langendijk JA, Halmos GB, Plaat BEC. van den Bovenkamp K, et al. Among authors: van der laan bfam, van dijk bac, van der vegt b. Oral Oncol. 2018 Feb;77:131-136. doi: 10.1016/j.oraloncology.2017.12.017. Epub 2018 Jan 8. Oral Oncol. 2018. PMID: 29362119
High sensitivity and negative predictive value of sentinel lymph node biopsy in a retrospective early stage oral cavity cancer cohort in the Northern Netherlands.
Boeve K, Schepman KP, Schuuring E, Roodenburg JLN, Halmos GB, van Dijk BAC, Boorsma RAC, de Visscher JGAM, Brouwers AH, van der Vegt B, Witjes MJH. Boeve K, et al. Among authors: van dijk bac, van der vegt b. Clin Otolaryngol. 2018 Aug;43(4):1080-1087. doi: 10.1111/coa.13107. Epub 2018 Apr 19. Clin Otolaryngol. 2018. PMID: 29575685
Data-Driven prioritisation of antibody-drug conjugate targets in head and neck squamous cell carcinoma.
Hanemaaijer SH, van Gijn SE, Oosting SF, Plaat BEC, Moek KL, Schuuring EM, van der Laan BFAM, Roodenburg JLN, van Vugt MATM, van der Vegt B, Fehrmann RSN. Hanemaaijer SH, et al. Among authors: van der laan bfam, van vugt matm, van gijn se, van der vegt b. Oral Oncol. 2018 May;80:33-39. doi: 10.1016/j.oraloncology.2018.03.005. Epub 2018 Mar 27. Oral Oncol. 2018. PMID: 29706186
165 results